Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Mar;21(3):271–277. doi: 10.1111/j.1365-2125.1986.tb05190.x

Stereoselective interaction between the R enantiomer of warfarin and cimetidine.

I A Choonara, S Cholerton, B P Haynes, A M Breckenridge, B K Park
PMCID: PMC1400859  PMID: 2938614

Abstract

The stereoselectivity of the pharmacokinetic interaction between warfarin and cimetidine was investigated in eight healthy volunteers. The warfarin enantiomers were given separately as single doses (15 mg) alone and during chronic administration of cimetidine (1 g day-1). Cimetidine did not interact with S warfarin but there was an interaction with the R enantiomer of warfarin. Cimetidine caused a significant increase in the mean plasma half-life of R warfarin (from 47.8 h to 57.8 h) and a significant decrease in its mean plasma clearance (from 2.3 to 1.7 ml h-1 kg-1) (P less than 0.02). Administration of a pharmacological dose of vitamin K1 together with the enantiomers of warfarin was necessary clinically and resulted in elevation of vitamin K1 2,3-epoxide concentrations, which were similar in each case.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banfield C., O'Reilly R., Chan E., Rowland M. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. Br J Clin Pharmacol. 1983 Dec;16(6):669–675. doi: 10.1111/j.1365-2125.1983.tb02239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell R. G. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle. Fed Proc. 1978 Oct;37(12):2599–2604. [PubMed] [Google Scholar]
  3. Breckenridge A. M., Cholerton S., Hart J. A., Park B. K., Scott A. K. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit. Br J Pharmacol. 1985 Jan;84(1):81–91. [PMC free article] [PubMed] [Google Scholar]
  4. Breckenridge A., Orme M., Wesseling H., Lewis R. J., Gibbons R. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther. 1974 Apr;15(4):424–430. doi: 10.1002/cpt1974154424. [DOI] [PubMed] [Google Scholar]
  5. Choonara I. A., Scott A. K., Haynes B. P., Cholerton S., Breckenridge A. M., Park B. K. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients. Br J Clin Pharmacol. 1985 Dec;20(6):643–648. doi: 10.1111/j.1365-2125.1985.tb05123.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hetzel D. J., Bochner F., Hallpike J. F., Shearman D. J., Hann C. S. Cimetidine interaction with phenytoin. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1512–1512. doi: 10.1136/bmj.282.6275.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaminsky L. S., Dunbar D. A., Wang P. P., Beaune P., Larrey D., Guengerich F. P., Schnellmann R. G., Sipes I. G. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab Dispos. 1984 Jul-Aug;12(4):470–477. [PubMed] [Google Scholar]
  8. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  9. Lewis R. J., Trager W. F., Chan K. K., Breckenridge A., Orme M., Roland M., Schary W. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest. 1974 Jun;53(6):1607–1617. doi: 10.1172/JCI107711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. O'Reilly R. A. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man. Circulation. 1982 Jan;65(1):202–207. doi: 10.1161/01.cir.65.1.202. [DOI] [PubMed] [Google Scholar]
  11. O'Reilly R. A. Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. N Engl J Med. 1980 Jan 3;302(1):33–35. doi: 10.1056/NEJM198001033020106. [DOI] [PubMed] [Google Scholar]
  12. O'Reilly R. A. Studies on the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther. 1974 Aug;16(2):348–354. doi: 10.1002/cpt1974162348. [DOI] [PubMed] [Google Scholar]
  13. O'Reilly R. A. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med. 1976 Aug 12;295(7):354–357. doi: 10.1056/NEJM197608122950702. [DOI] [PubMed] [Google Scholar]
  14. Park B. K., Scott A. K., Wilson A. C., Haynes B. P., Breckenridge A. M. Plasma disposition of vitamin K1 in relation to anticoagulant poisoning. Br J Clin Pharmacol. 1984 Nov;18(5):655–662. doi: 10.1111/j.1365-2125.1984.tb02526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schmidt W., Beermann D., Oesch F., Jähnchen E. Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma. J Pharm Pharmacol. 1979 Jul;31(7):490–491. doi: 10.1111/j.2042-7158.1979.tb13567.x. [DOI] [PubMed] [Google Scholar]
  16. Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
  17. Shearer M. J., McBurney A., Breckenridge A. M., Barkhan P. Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man. Clin Sci Mol Med. 1977 Jun;52(6):621–630. doi: 10.1042/cs0520621. [DOI] [PubMed] [Google Scholar]
  18. Somogyi A., Gugler R. Drug interactions with cimetidine. Clin Pharmacokinet. 1982 Jan-Feb;7(1):23–41. doi: 10.2165/00003088-198207010-00002. [DOI] [PubMed] [Google Scholar]
  19. Somogyi A., Rohner H. G., Gugler R. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet. 1980 Jan-Feb;5(1):84–94. doi: 10.2165/00003088-198005010-00003. [DOI] [PubMed] [Google Scholar]
  20. Willingham A. K., Matschiner J. T. Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat. Biochem J. 1974 Jun;140(3):435–441. doi: 10.1042/bj1400435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wilson A. C., Park B. K. Quantitative analysis of pharmacological levels of vitamin K1 and vitamin K1 2,3-epoxide in rabbit plasma by high-performance liquid chromatography. J Chromatogr. 1983 Oct 14;277:292–299. doi: 10.1016/s0378-4347(00)84847-1. [DOI] [PubMed] [Google Scholar]
  22. Wingard L. B., Jr, O'Reilly R. A., Levy G. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations. Clin Pharmacol Ther. 1978 Feb;23(2):212–217. doi: 10.1002/cpt1978232212. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES